Influential proxy firms kick back at activists’ demands for Brent Saunders to give up his chairman’s title at Allergan

Influential proxy firms kick back at activists’ demands for Brent Saunders to give up his chairman’s title at Allergan

Source: 
Endpoints
snippet: 

After saving Bristol-Myers Squibb last week from the embarrassing disaster of seeing its $74 billion Celgene buyout go south, the proxy advisory firms Institutional Shareholder Services and Glass Lewis are back at it today protecting Allergan CEO Brent Saunders in his fight to preserve his control of both the CEO and chairman titles.